Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Selective class IIa HDAC inhibitors: myth or reality
Eros Di Giorgio, Enrico Gagliostro, Claudio Brancolini
Cellular and Molecular Life Sciences (2014) Vol. 72, Iss. 1, pp. 73-86
Closed Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages
Jennifer L. Guerriero, Alaba Sotayo, Holly Ponichtera, et al.
Nature (2017) Vol. 543, Iss. 7645, pp. 428-432
Open Access | Times Cited: 482
Targeting Tumor-Associated Macrophages as a Potential Strategy to Enhance the Response to Immune Checkpoint Inhibitors
Luca Cassetta, Takanori Kitamura
Frontiers in Cell and Developmental Biology (2018) Vol. 6
Open Access | Times Cited: 188
Lysine acetylation and cancer: A proteomics perspective
Jeovanis Gil, Alberto Ramírez-Torres, Sergio Encarnación
Journal of Proteomics (2016) Vol. 150, pp. 297-309
Closed Access | Times Cited: 165
The Search for Potent, Small‐Molecule HDACIs in Cancer Treatment: A Decade After Vorinostat
Chiara Zagni, Giuseppe Floresta, Giulia Monciino, et al.
Medicinal Research Reviews (2017) Vol. 37, Iss. 6, pp. 1373-1428
Closed Access | Times Cited: 117
Regulation of Class IIa HDAC Activities: It is Not Only Matter of Subcellular Localization
Eros Di Giorgio, Claudio Brancolini
Epigenomics (2016) Vol. 8, Iss. 2, pp. 251-269
Open Access | Times Cited: 115
The Therapeutic Strategy of HDAC6 Inhibitors in Lymphoproliferative Disease
Maria Cosenza, Samantha Pozzi
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 8, pp. 2337-2337
Open Access | Times Cited: 72
MEF2 and the tumorigenic process, hic sunt leones
Eros Di Giorgio, Wayne W. Hancock, Claudio Brancolini
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2018) Vol. 1870, Iss. 2, pp. 261-273
Open Access | Times Cited: 69
Recent advances in class IIa histone deacetylases research
Yodita Asfaha, Christian Schrenk, Leandro A. Alves Avelar, et al.
Bioorganic & Medicinal Chemistry (2019) Vol. 27, Iss. 22, pp. 115087-115087
Closed Access | Times Cited: 57
Apoptosis Induction byHistone Deacetylase Inhibitors in Cancer Cells: Role of Ku70
Ping Gong, Yuetong Wang, Yongkui Jing
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 7, pp. 1601-1601
Open Access | Times Cited: 56
Histone deacetylase 7: a signalling hub controlling development, inflammation, metabolism and disease
Yizhuo Wang, Rishika Abrol, Jeffrey Y. W. Mak, et al.
FEBS Journal (2022) Vol. 290, Iss. 11, pp. 2805-2832
Open Access | Times Cited: 37
HDAC4 in cancer: A multitasking platform to drive not only epigenetic modifications
Emma Cuttini, Camilla Goi, Ester Pellarin, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 17
HDAC4 influences the DNA damage response and counteracts senescence by assembling with HDAC1/HDAC2 to control H2BK120 acetylation and homology-directed repair
Eros Di Giorgio, Emiliano Dalla, Vanessa Tolotto, et al.
Nucleic Acids Research (2024) Vol. 52, Iss. 14, pp. 8218-8240
Open Access | Times Cited: 6
TMP195 Exerts Antitumor Effects on Colorectal Cancer by Promoting M1 Macrophages Polarization
Yicheng Han, Jiachun Sun, Yanyan Yang, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 15, pp. 5653-5666
Open Access | Times Cited: 25
Transcriptomic and genomic studies classify NKL54 as a histone deacetylase inhibitor with indirect influence on MEF2-dependent transcription
Martina Minisini, Eros Di Giorgio, Emanuela Kerschbamer, et al.
Nucleic Acids Research (2022) Vol. 50, Iss. 5, pp. 2566-2586
Open Access | Times Cited: 19
The role of class IIa histone deacetylases in regulating endothelial function
Zexu Shen, Yun Bei, Haoran Lin, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 11
Insights into the function of HDAC3 and NCoR1/NCoR2 co-repressor complex in metabolic diseases
Harikrishnareddy Paluvai, Kumar D. Shanmukha, Jens Tyedmers, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 11
The catalytic domain of free or ligand bound histone deacetylase 4 occurs in solution predominantly in closed conformation
Markus Schweipert, Thomas Nehls, Anton Frühauf, et al.
Protein Science (2024) Vol. 33, Iss. 3
Open Access | Times Cited: 4
Discovery of a potential hematologic malignancies therapy: Selective and potent HDAC7 PROTAC degrader targeting non-enzymatic function
Yuheng Jin, Xuxin Qi, Xiaoli Yu, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Epigenetic regulation of skeletal muscle metabolism
Kirsten F. Howlett, Sean L. McGee
Clinical Science (2016) Vol. 130, Iss. 13, pp. 1051-1063
Closed Access | Times Cited: 38
Nuclear translocation of histone deacetylase 4 induces neuronal death in stroke
Hui Yuan, Kyle Denton, Lin Liu, et al.
Neurobiology of Disease (2016) Vol. 91, pp. 182-193
Closed Access | Times Cited: 36
A Rational Approach for the Identification of Non-Hydroxamate HDAC6-Selective Inhibitors
Laura Goracci, Nathalie Deschamps, Giuseppe Marco Randazzo, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 36
Salt‐inducible kinase induces cytoplasmic histone deacetylase 4 to promote vascular calcification
Alon Abend, Omer Shkedi, Michal Fertouk, et al.
EMBO Reports (2017) Vol. 18, Iss. 7, pp. 1166-1185
Open Access | Times Cited: 34
HDAC7‐mediated control of tumour microenvironment maintains proliferative and stemness competence of human mammary epithelial cells
Valentina Cutano, Eros Di Giorgio, Martina Minisini, et al.
Molecular Oncology (2019) Vol. 13, Iss. 8, pp. 1651-1668
Open Access | Times Cited: 34
Histone deacetylases: A novel class of therapeutic targets for pancreatic cancer
Xuesong Xiang, Pengcheng Li, Wenquan Wang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 1, pp. 188676-188676
Closed Access | Times Cited: 18
HDAC-driven mechanisms in anticancer resistance: epigenetics and beyond
Martina Minisini, Massimo Mascaro, Claudio Brancolini
Cancer Drug Resistance (2024)
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top